Physicians who exhibit chronic disruptive behavior are a liability risk in hospitals. We're not talking about physicians who have an irascible personality or who occasionally lash out in frustration, but rather those physicians who habitually and continually cause disruptions by, say, using abusive or threatening language or refusing to believe that they could be wrong.
Disruptive physicians tear down staff morale and stifle communication: For example, staff members who are turned off or intimidated by the disruptive physician's behavior may eventually avoid interacting with him or her. This could result in delays in communicating essential information about a patient's care. If a patient is harmed as a result, the hospital could be held liable.
Because of this risk, "medical staff and leadership have the responsibility of trying to eliminate the behavior," says ACOG Today (Nov/Dec 2003). Observing the right to due process, the American Medical Association recommends that disruptive physicians be treated as if they had a substance abuse impairment and referred to a medical staff wellness committee or the equivalent. Whether the disruptive physician can modify his or her behaviorthereby decreasing the threat to the delivery of safe patient carewill determine if the physician must be removed from the medical staff.
Thinner endometrial thickness linked to higher placenta accreta spectrum risk
November 29th 2024A recent study reveals that reduced endometrial thickness significantly increases the risk of placenta accreta spectrum disorders in women without prior cesarean deliveries using assisted reproductive technology.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More